Obesity and cardiovascular risk
Clinical trials for Obesity and cardiovascular risk explained in plain language.
Never miss a new study
Get alerted when new Obesity and cardiovascular risk trials appear
Sign up with your email to follow new studies for Obesity and cardiovascular risk, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A new blueprint for obesity care: does structure beat standard treatment?
Disease control Recruiting nowThis study tests whether a structured, multidisciplinary obesity care program—which may include the weight-loss drug semaglutide—helps adults with obesity lose more weight than usual care. Adults aged 18-65 with a BMI of 30 or higher will be followed for 18 months to see if they …
Matched conditions: OBESITY AND CARDIOVASCULAR RISK
Sponsor: University of Health Sciences, Algeria • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a common diabetes drug help obese nigerians lose weight?
Disease control Recruiting nowThis study tests whether metformin, a drug already used for diabetes, can help obese but non-diabetic Black Nigerians lose weight and lower their heart disease risk. Researchers will give 220 participants either metformin or a placebo for several months, tracking changes in weigh…
Matched conditions: OBESITY AND CARDIOVASCULAR RISK
Phase 3 • Sponsor: University Of Nigeria Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC